Outcomes after liver transplantation: Chronic kidney disease

Liver Transplantation

Volumn 15, Issue SUPPL. 2, 2009, Pages

  Bahirwani, Ranjeeta ^a   Reddy, K Rajender ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; IMMUNOSUPPRESSIVE AGENT; CALCINEURIN; CREATININE;

ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; GRAFT SURVIVAL; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LIVER TRANSPLANTATION; NEPHROTOXICITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURVIVAL; BLOOD; CHEMICALLY INDUCED DISORDER; CHRONIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; METHODOLOGY; MORTALITY; RISK FACTOR; TREATMENT OUTCOME;

CALCINEURIN; CHRONIC DISEASE; CREATININE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TREATMENT OUTCOME;

EID: 77449102129     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21900     Document Type: Article

References (32)

1. Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-939.
2. Cohen AJ, Stegall MD, Rosen CB, Wiesner RH, Leung N, Kremers WK, Zein NN,. Chronic renal dysfunction late after liver transplantation. Liver Transpl 2002; 8: 916-921. (Pubitemid 35154021)
3. Gonwa TA, Jennings L, Mai ML, Stark PC, Levey AS, Klintmalm GB,. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl 2004; 10: 301-309. (Pubitemid 38240131)
4. Gonwa TA, Mai ML, Melton LB, Hays SR, Goldstein RM, Levy MF, Klintmalm GB,. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin based immunotherapy: risk of development and treatment. Transplantation 2001; 72: 1934-1939.
5. Bilbao I, Charco R, Balsells J, Lazaro JL, Hidalgo E, Llopart L, et al. Risk factors for acute renal failure requiring dialysis after liver transplantation. Clin Transplant 1998; 12: 123-129. (Pubitemid 128721313)
6. Lafayette RA, Paré G, Schmid CH, King AJ, Rohrer RJ, Nasraway SA,. Pretransplant renal dysfunction predicts poorer outcome in liver transplantation. Clin Nephrol 1997; 48: 159-164.
7. Pawarode A, Fine DM, Thuluvath PJ,. Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transpl 2003; 9: 741-747. (Pubitemid 36874464)
8. Bloom RD, Reese RP,. Chronic kidney disease after nonrenal solid-organ transplantation. J Am Soc Nephrol 2007; 18: 3031-3041. (Pubitemid 350223963)
9. Margreiter R, Königsrainer A, Spechtenhauser B, Ladurner R, Pomarolli A, Hörmann C, et al. Our experience with combined liver-kidney transplantation: an update. Transplant Proc 2002; 34: 2491-2492. (Pubitemid 35299834)
10. Seu P, Wilkinson AH, Shaked A, Busuttil RW,. The hepatorenal syndrome in liver transplant recipients. Am Surg 1991; 57: 806-809.
11. Campbell MS, Kotlyar DS, Brensinger CM, Lewis JD, Shetty K, Bloom RD, et al. Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transpl 2005; 11: 1048-1055. (Pubitemid 41341753)
12. Davis CL, Gonwa TA, Wilkinson AH,. Identification of patients best suited for combined liver-kidney transplantation: part II. Liver Transpl 2002; 8: 193-211.
13. Pham PT, Pham PC, Wilkinson AH,. Renal function outcomes following liver transplantation and combined liver-kidney transplantation. Nat Clin Pract Nephrol 2007: 3: 507-514 (Pubitemid 47313029)
14. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR,. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326-2333. (Pubitemid 37509740)
15. McGuire BM, Julian BA, Bynon JS Jr, Cook WJ, King SJ, Curtis JJ, et al. Brief communication: glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Ann Intern Med 2006; 144: 735-741. (Pubitemid 46780633)
16. Khalili M, Lim JW, Bass N, Ascher NL, Roberts JP, Terrault NA, et al. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transpl 2004; 10: 349-355. (Pubitemid 38380307)
17. Yalavarthy R, Edelstein CL, Teitelbaum I,. Acute renal failure and chronic kidney disease following liver transplantation. Hemodial Int 2007; 11 (suppl 3): S7-12 (Pubitemid 47491285)
18. Gonwa TA, Mai ML, Melton LB, Hays SR, Goldstein RM, Levy MF, Klintmalm GB,. Renal replacement therapy and orthotopic liver transplantation: The role of continuous veno-venous hemodialysis. Transplantation 2001; 71: 1424-1428.
19. Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS, Sarnak MJ,. The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD. Am J Kidney Dis 2008; 51: 212-223.
20. American Diabetes Association. Standards of medical care in diabetes-2009. Diabetes Care 2009; 32: S13-S61.
21. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7). Hypertension 2003; 42: 1206
22. Farkas SA, Schnitzbauer AA, Kirchner G, Obed A, Banas B, Schlitt HJ,. Calcineurin inhibitor minimization protocols in liver transplantation. Transpl Int 2009; 22: 49-60.
23. Campbell MS, Rai J, Kozin E, Bloom RD, Markmann JF, Olthoff KM, et al. Effects of sirolimus vs. calcineurin inhibitors on renal dysfunction after orthotopic liver transplantation. Clin Transplant 2007; 21: 377-384. (Pubitemid 46711401)
24. DuBay D, Smith RJ, Qiu KG, Levy GA, Lilly L, Therapondos G,. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens. Liver Transpl 2008; 14: 651-659. (Pubitemid 351696277)
25. Davis CL, Feng S, Sung R, Wong F, Goodrich NP, Melton LB, et al. Simultaneous liver-kidney transplantation: evaluation to decision making. Am J Transplant 2007; 7: 1702-1709. (Pubitemid 46905445)
26. 2007 OPTN/SRTR Annual Report: Transplant Data 1997-2006. Rockville, MD: Department of Health and Human Services; 2007.
27. Bahirwani R, Campbell MS, Siropaides T, Markmann J, Olthoff K, Shaked A, et al. Transplantation: impact of pretransplant renal insufficiency. Liver Transpl 2008; 14: 665-671 (Pubitemid 351696279)
28. Ruiz R, Barri YM, Jennings LW, Chinnakotla S, Goldstein RM, Levy MF, et al. Hepatorenal syndrome: a proposal for kidney after liver transplantation (KALT). Liver Transpl 2007; 13: 838-843. (Pubitemid 46947848)
29. Opelz G, Margreiter R, Döhler B,. Prolongation of long term kidney graft survival by a simultaneous liver transplant: the liver does it, and the heart does it too. Transplantation 2002; 74: 1390-1394. (Pubitemid 35379543)
30. Olausson M, Mjörnstedt L, Nordén G, Rydberg L, Mölne J, Bäckman L, Friman S,. Successful combined partial auxiliary liver and kidney transplantation in highly sensitized cross-match positive recipients. Am J Transplant 2007; 7: 130-136. (Pubitemid 44952865)
31. Chava SP, Singh B, Zaman MB, Rela M, Heaton ND,. Current indications for combined liver and kidney transplantation in adults. Transplant Rev 2009; 23: 111-119.
32. National Kidney Foundation. KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39: S1-S266.